Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NB01 in adults with moderate acne
NCT03709654Phase 1Completed
- Sponsor
- Naked Biome
- Start
- Nov 2018
- Primary completion
- Sep 2019
- Modality
- Small Molecules, Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of DA-9801 in acne vulgaris (2 arms), sponsored by Naked Biome. Primary endpoints: Number of Participants With Changes in Local Skin Reactions, Number of Participants With Successful Follicular Engraftment of NB01 at 12 weeks and 5 more. Started Nov 2018; status: completed.
02
Drugs
DA-9801
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT03709654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03709654.